poisar

Stock

Sunshine Biopharma Inc. SBFM

$1.29+3.20%

Overview

SBFM market data

Price History

SBFM price chart · 1M
O
1.22
H
1.30
L
1.18
C
1.29
Vol
8,060.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$1.22
Previous Close
$1.25
Day High
$1.30
Day Low
$1.18
52 Week High
$23.05
52 Week Low
$1.04
7 Day Return
+12.17%
30 Day Return
-9.79%
90 Day Return
-49.90%
1 Year Return
-86.43%
Daily Notional Volume
$10.4K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$14.37
Diluted earnings per share over the trailing twelve months.
Beta
-8.93
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-17.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.03 – $24.30
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $2.9M · P/B 0.26 · P/S 0.08.

Company News

10 captured
Sunshine Biopharma Announces Updates On Its K1.1 mRNA Tumor Suppressor; Outlines Plans For ProgramBenzinga · Aug 26, 2026, 1:03 PM
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung CancerBenzinga · Aug 26, 2026, 12:31 PM
EXCLUSIVE: Sunshine Biopharma Reports Preclinical Tumor Suppression with K1.1 mRNA in Liver Cancer; Advances mRNA-Cancer Vaccine for Difficult-to-Treat Lung CancerBenzinga · Aug 26, 2026, 12:30 PM
Sunshine Biopharma Announces Approval Of Generic Enalapril Tablets 2.5mg, 5mg, 10mg And 20mg For Canadian MarketBenzinga · Aug 19, 2026, 1:02 PM
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension DrugBenzinga · Aug 19, 2026, 12:30 PM
EXCLUSIVE: Sunshine Biopharma Receives Canadian Approval for Generic Enalapril for Hypertension in Four Dosage Strengths; Shipping To begin By Year-End 2026Benzinga · Aug 19, 2026, 12:30 PM
Sunshine Biopharma Announces Launch Of Generic Amoxicillin In Canada, Now Shipping To Pharmacies In Multiple Dosages And StrengthsBenzinga · Aug 7, 2026, 1:02 PM
Sunshine Biopharma shares are trading higher after the company announced the approval of its generic Dienogest tablets of 2mg for the Canadian market.Benzinga · Aug 4, 2026, 6:29 PM
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug ApprovalBenzinga · Aug 4, 2026, 12:31 PM
EXCLUSIVE: Sunshine Biopharma Gets Canadian Regulatory Approval Of Generic Dienogest TabletsBenzinga · Aug 4, 2026, 12:30 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Sunshine Biopharma Inc. (SBFM) stock — price, valuation & news | Poisar